JCJiann-Torng Chen

Jiann-Torng Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jiann-Torng Chen has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Da-Wen Lu

    Graduate Institute of Medical Science, National Defense Medical Center, No. 161, Section 6, Minquan East Road, Taipei 114, Taiwan

    6 shared publications
  • Yi-Hao Chen

    Graduate Institute of Medical Science, National Defense Medical Center, No. 161, Section 6, Minquan East Road, Taipei 114, Taiwan

    6 shared publications
  • Yun-Hsiang Chang

    Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Cheng-Kong Road, Taipei 114, Taiwan

    6 shared publications
  • Ching-Long Chen

    Graduate Institute of Medical Science, National Defense Medical Center, No. 161, Section 6, Minquan East Road, Taipei 114, Taiwan

    5 shared publications
  • Chang-Min Liang

    Graduate Institute of Medical Science, National Defense Medical Center, No. 161, Section 6, Minquan East Road, Taipei 114, Taiwan

    4 shared publications
  • Ming-Cheng Tai

    Graduate Institute of Medical Science, National Defense Medical Center, No. 161, Section 6, Minquan East Road, Taipei 114, Taiwan

    4 shared publications

Latest Publications

  • Open Access

    Silibinin Inhibits ICAM-1 Expression via Regulation of N-Linked and O-Linked Glycosylation in ARPE-19 Cells

    by Yi-Hao Chen, Ching-Long Chen, Chang-Min Liang, Jy-Been Liang, Ming-Cheng Tai, Yun-Hsiang Chang, Da-Wen Lu, Jiann-Torng Chen

    To evaluate the effects of silibinin on intercellular adhesion molecule-1 (ICAM-1) expression, we used ARPE-19 cells as a model in which tumor necrosis factor (TNF-α) and interferon (IFN-γ) enhanced ICAM-1 expression. This upregulation was inhibited by silibinin. In an adherence assay using ARPE-19 and THP-1 cells, silibinin inhibited the cell adhesion function of ICAM-1. The inhibitory effects of silibinin on ICAM-1 expression were mediated via the blockage of nuclear translocation of p65 proteins in TNF-α and phosphorylation of STAT1 in IFN-γ-stimulated cells. In addition, silibinin altered the degree of N-linked glycosylation posttranslationally in ARPE-19 cells by significantly enhancing MGAT3 gene expression. Silibinin can increase the O-GlcNAc levels of glycoproteins in ARPE-19 cells. In a reporter gene assay, PUGNAc, which can also increase O-GlcNAc levels, inhibited NF-κB reporter activity in TNF-α-induced ARPE-19 cells and this process was augmented by silibinin treatment. Overexpression of OGT gene was associated with reduced TNF-α-induced ICAM-1 levels, which is consistent with that induced by silibinin treatment. Taken together, silibinin inhibits ICAM-1 expression and its function through altered O-linked glycosylation in NF-κB and STAT1 signaling pathways and decreases the N-linked glycosylation of ICAM-1 transmembrane protein in proinflammatory cytokine-stimulated ARPE-19 cells.


  • Open Access

    Bevacizumab modulates epithelial‐to‐mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up‐regulation

    by Ching‐Long Chen, Chang‐Min Liang, Yi‐Hao Chen, Ming‐Cheng Tai, Da‐Wen Lu, Jiann‐Torng Chen

    : Purpose:  To investigate the effect of bevacizumab treatment on connective tissue growth factor (CTGF) expression and the induction of epithelial‐to‐mesenchymal transition in ARPE‐19 cells and human donor retinal pigment epithelium (HRPE) cells in vitro.Methods:  We quantitated the protein and gene expression level of CTGF by ELISA. The effect of Fc–Fc receptor (Fc–FcR) interaction on CTGF expression was evaluated by CD64 siRNA silencing. Expression of epithelial‐to‐mesenchymal transition markers, alpha‐smooth muscle actin (α‐SMA) and zona occludens protein (ZO‐1) was evaluated by Western blot. Cell migration and collagen gel contraction assay were examined by light microscopy, and collagen production was measured by ELISA.Results:  Bevacizumab stimulation increased CTGF expression in ARPE‐19 and HRPE cells in a dose‐dependent manner. CD64 gene silencing inhibited the effect of bevacizumab‐induced CTGF up‐regulation. Bevacizumab increased the expression of α‐SMA and decreased the expression of ZO‐1 in ARPE‐19 cells. Bevacizumab also caused the release of type‐1 collagen and increased cell migration and contraction of collagen.Conclusions:  Bevacizumab exerts pro‐fibrotic effects on human RPE cells at clinical doses by up‐regulation of CTGF expression via an Fc–FcR interaction. This effect of bevacizumab may be one of the underlying mechanisms involved in age‐related macular degeneration therapy or intravitreal bevacizumab‐associated complications.


  • Open Access

    Glucosamine Modulates TNF-α–Induced ICAM-1 Expression and Function Through O-Linked and N-Linked Glycosylation in Human Retinal Pigment Epithelial Cells

    by Ching-Long Chen, Chang-Min Liang, Yi-Hao Chen, Ming-Cheng Tai, Da-Wen Lu, Jiann-Torng Chen

    Purpose: The purpose of this article was to investigate the effects of glucosamine (GlcN) on the TNF-α–induced expression of intercellular adhesion molecule 1 (ICAM-1) and the function of ICAM-1 in ARPE-19 cells in vitro. Methods: We quantified protein levels of TNF-α–induced ICAM-1 in ARPE-19 cells with Western blotting. The effects of GlcN on O-linked glycosylation, and therefore on ICAM-1 expression, were compared after the addition of alloxan, an inhibitor of O-linked N-acetylglucosamine transferase (OGT), or O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), an inhibitor of N-acetylglucosaminidase (O-GlcNAcase [OGA]), or after OGT gene overexpression. The effect of GlcN on the N-linked glycosylation of ICAM-1 was evaluated by the change in its molecular mass on Western blotting. The effect of O-linked glycosylation on the nuclear factor κB (NF-κB) signaling pathway was examined using an NF-κB reporter gene assay. The effect of GlcN on ICAM-1 adhesion activity was examined using an ICAM-1 adhesion assay. Results: GlcN, PUGNAc, and OGT overexpression inhibited TNF-α–induced ICAM-1 expression and NF-κB activity in ARPE-19 cells. Alloxan increased ICAM-1 expression and NF-κB activity in TNF-α–induced ARPE-19 cells. GlcN and tunicamycin reduced the molecular mass of TNF-α–induced ICAM-1 in ARPE-19 cells. The proteasome inhibitor MG-132 suppressed the GlcN-induced reduction in the molecular mass of TNF-α–induced ICAM-1. GlcN also attenuated the adhesion activity of TNF-α–induced ICAM-1. Conclusions: GlcN inhibits ICAM-1 expression and functions by modulating the O-linked glycosylation of factors involved in NF-κB signaling and by reducing the N-linked glycosylation of TNF-α–induced ICAM-1 in ARPE-19 cells. These effects may contribute to the GlcN-mediated anti-inflammatory effects in the eye.


  • Open Access

    Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy

    by Chang-Min Liang, Ming-Cheng Tai, Yun-Hsiang Chang, Yi-Hao Chen, Ching-Long Chen, Da-Wen Lu, Jiann-Torng Chen

    Purpose: To explore the effect of glucosamine (GlcN) on transforming growth factor (TGF)-β signalling and several processes involved in proliferative vitreoretinopathy (PVR). Methods: We evaluated the surface levels of TGF-β receptor and its binding of TGF-β in ARPE-19 cells. Release of cytokines and collagen, and expression of signalling intermediates were quantified. Migration was qualitatively and quantitatively examined. The morphology of cells undergoing PVR in vitro and in a mouse PVR model was observed. Results: Glucosamine reduced the surface levels of TGF-β receptor and the ability of ARPE-19 cells to bind TGF-β. In ARPE-19 cells, TGF-β1 plus epidermal growth factor (EGF) or TGF-β2 increased the expression of alpha-smooth muscle actin (α-SMA) and decreased the expression of zona occludens protein (ZO-1). Transforming growth factor-(β2) also caused the release of platelet-derived growth factor (PDGF), connective tissue growth factor (CTGF) and type 1 collagen and increased the phosphorylation of SMAD2 and SMAD3. Platelet-derived growth factor and CTGF stimulated cell migration, and TGF-β2 stimulated wound closure, contraction of collagen and changes in cell morphology. Conclusions: Treatment with GlcN counteracted all of these effects, and its administration in the mouse model reduced the morphologic appearance of PVR. Glucosamine could inhibit the TGF-β signalling pathway in retinal pigment epithelium cells and several of the downstream events associated with epithelial–mesenchymal transition and PVR.


  • Open Access

    Acute endophthalmitis after cataract surgery at a referral centre in Northern Taiwan: review of the causative organisms, antibiotic susceptibility, and clinical features

    by J-H Cheng, Y-H Chang, C-L Chen, Y-H Chen, D-W Lu, J-T Chen

    The aims of this study were to describe the bacterial isolates and treatment outcomes of endophthalmitis after cataract surgery at a referral centre in Northern Taiwan. This was a retrospective, interventional, and observational series. Medical records were review of patients with clinical diagnosed, and/or culture-proven bacterial endophthalmitis at a tertiary referral centre in Northern Taiwan from January 2002 to December 2008. Treatment generally conformed to standard guidelines. Main outcome measurements were results of organism culture, antibiotic susceptibility of isolated bacteria, and visual acuity (VA) outcome. Thirty-four patients had positive cultures. A total of 55.9% of the culture-positive isolates were Gram negative and 44.1% were Gram positive. Pseudomonas aeruginosawas the most commonly isolated organism. Eighteen patients had final VA better than 5/200, and 41 had final VA worse than 5/200. In multiple linear regression analysis, female gender, presence of hypopyon, and worse baseline VA were significant independent predictors of worse visual outcome. It was found that at a referral centre in Northern Taiwan, the majority of bacterial isolates were Gram negative in acute postoperative bacterial endophthalmitis after cataract surgery and P. aeruginosawas the most common bacterial isolate.


  • Open Access

    Inhibitory Effects of Glucosamine on Endotoxin-Induced Uveitis in Lewis Rats

    by Yun-Hsiang Chang, Chi-Ting Horng, Yi-Hao Chen, Po-Liang Chen, Ching-Long Chen, Chang-Min Liang, Ming-Wei Chien, Jiann-Torng Chen

    Purpose. Glucosamine sulfate (GS) is a naturally occurring sugar that exerts immunosuppressive effects in vitro and in vivo. The authors investigated whether GS modulates the inflammatory reaction in endotoxin-induced uveitis (EIU) of rats and the mechanisms by which it exerts its effects. methods. Two-hundred micrograms of lipopolysaccharide (LPS) was injected subcutaneously into Lewis rats to induce EIU. Doses of GS (10, 100, or 1000 mg/kg) were divided into three aliquots and administered intraperitoneally 30 minutes before LPS injection, concurrently with LPS injection, and 30 minutes after LPS injection. Twenty-four hours after LPS injection, aqueous humor was collected for cell counting and measurement of protein concentration. Immunohistochemical staining of the iris-ciliary body was performed to evaluate the effects of GS on intercellular adhesion molecule (ICAM)-1 and nuclear factor (NF)-κB activation and to demonstrate macrophage infiltration. The effects of various doses of GS pretreatment were also examined using a mouse macrophage cell line (RAW264.7 cells) and LPS stimulation. Levels of prostaglandin (PG)-E2 and nitric oxide (NO) were determined. Expression of inducible NO synthase (iNOS) and cyclooxygenase (COX)-2 were measured using Western blot analysis. The effect of GS on LPS-induced NF-κB activation in RAW cells was also examined. results. Cell counting and analysis of protein concentration in aqueous humor revealed that GS suppressed EIU in rats treated with a high dose of GS (1000 mg/kg). Immunohistochemistry showed that treatment with GS reduced ICAM-1 expression and suppressed activation of NF-κB in the iris-ciliary body. The main inflammatory cells in the iris-ciliary body during EIU were macrophages. In LPS-stimulated macrophage RAW cell culture, GS inhibited the production of NO and PG-E2, the expression of iNOS and COX-2, and the activation of NF-κB. conclusions. GS suppresses EIU in rats by blockading the NF-κB–dependent signaling pathway and the subsequent production of ICAM-1 and proinflammatory mediators. This study has extended the authors’ previous observation that GS is a potentially important compound for reducing ICAM-1–mediated inflammatory effects in the eye.


  • Glucosamine Sulfate Inhibits Proinflammatory Cytokine-Induced ICAM-1 Production in Human Conjunctival Cells In Vitro

    by Jiann-Torng Chen, Chiao-Hong Chen, Chi-Ting Horng, Ming-Wei Chien, Da-Wen Lu, Jy-Been Liang, Ming-Cheng Tai, Yun-Hsiang Chang, Po Liang Chen, Yi-Hao Chen

    Purpose: We investigated whether glucosamine sulfate modulates the production of ICAM-1 induced by proinflammatory cytokines and whether glucosamine sulfate inhibits leukocyte adhesion to a monolayer of human conjunctival epithelial cells stimulated with proinflammatory cytokines. Methods: We used flow cytometry and either primary cultured human conjunctival cells or the Chang conjunctival cell model to determine the effects of glucosamine sulfate on the production of ICAM-1 in response to tumor necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-1β, IL-6, (TNF)-α plus (IFN)-γ, or (TNF)-α plus (IL)-1β. The effects of glucosamine sulfate on the expression of the ICAM-1 gene, upregulated by various cytokines, were determined by semiquantitative reverse transcription–polymerase chain reaction. The activation and nuclear translocation of the nuclear factors NF-κB and STAT1 were evaluated by the transient transfection of reporter gene systems and immunocytochemistry. The influence of glucosamine-sulfate–modulated ICAM-1 on neutrophil adhesion was demonstrated in a model that measures the adherence of conjunctival cells and neutrophils. Results: (TNF)-α, (IFN)-γ, and (IL)-1β significantly increased the production of ICAM-1 by both primary cultured human conjunctival cells and Chang conjunctival cells. Glucosamine sulfate effectively downregulated the production of ICAM-1 induced by (TNF)-α, (IFN)-γ, (IL)-1β, (TNF)-α plus (IFN)-γ, or (TNF)-α plus (IL)-1β. This downregulation occurred through the interferon-stimulated response element, (IFN)-γ activation sequence, and binding sequence of NF-κB at the mRNA and protein levels. Glucosamine sulfate further inhibited the nuclear translocation of p65 protein in (TNF)-α- and (IL)-1β-stimulated Chang conjunctival cells and phosphorylated STAT1 in (IFN)-γ-stimulated Chang conjunctival cells. Glucosamine sulfate also significantly reduced the number of neutrophils adhering to a conjunctival monolayer in response to (TNF)-α, (IFN)-γ, or (IL)-1β. Conclusions: Our results suggest that glucosamine sulfate inhibits ICAM-1 production in conjunctival epithelial cells in vitro. Therefore, glucosamine sulfate might be valuable in the treatment of inflammatory ocular-surface conditions.


  • Glucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitro

    by Jiann-Torng Chen, Po-Liang Chen, Yun-Hsiang Chang, Ming-Wei Chien, Yi-Hao Chen, Da-Wen Lu


  • Hyperbaric oxygen therapy ameliorates the blood–retinal barrier breakdown in diabetic retinopathy

    by Yun‐Hsiang Chang, Po‐Liang Chen, Ming‐Cheng Tai, Chiao‐Hong Chen, Da‐Wen Lu, Jiann‐Torng Chen

    Background:  To study the effect of hyperbaric oxygen (HBO) therapy on diabetic retinopathy in a streptozotocin‐induced diabetic rat model.Methods:  Sprague–Dawley albino male rats were divided into three groups. The three groups were as follow: (i) non‐diabetic control group (non‐DM control); (ii) diabetic control group (DM control); and (iii) diabetic rats receiving hyperbaric oxygen therapy (DM HBO). Rats in DM HBO group were incubated in an oxygen monoplace chamber. The HBO condition was set at 2.5 atmospheres and 100% oxygen. The duration of a single HBO treatment was 90 min. Rats in DM HBO groups received HBO three times per week for 3 months. Retinal vascular permeability was assessed by measuring fluorescein isothiocyanate‐labelled bovine albumin and retinal Evans blue leakage into the retina.Results:  We found that the retinal parenchyma showed prominent thickening but not statistically significant in rats with DM, corresponding to the retinal oedema, compared with the control and DM HBO groups. fluorescein isothiocyanate relative fluorescence intensity (Mean ± SE) in normal control animals, diabetic animals, and HBO‐treated diabetic animals was 356 ± 47, 865 ± 78, and 518 ± 49, respectively, demonstrating significant difference between the means of diabetic and HBO‐treated diabetic animals, and between means of control and diabetic animals (n = 8, P < 0.05). Retinal Evans blue leakage in control animals, diabetic animals, and HBO‐treated diabetic animals was 7.6 ± 2.9, 18.5 ± 4.2 and 10.2 ± 3.1 µL plasma/g retinal dry weight/h, respectively, demonstrating significant difference between the means of diabetic and HBO‐treated diabetic animals, and between means of control and diabetic animals (n = 8, P < 0.05).Conclusions:  HBO therapy may diminish the extent of the increased blood–retinal barrier breakdown in diabetic animals.